Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Nikitin, Ea"'
Autor:
Alicia Enrico, Viktor Komlosi, Mary Ann Anderson, Kavita Sail, Ewa Lech-Marańda, Madhavi Pai, Shang-Ju Wu, Tara Cochrane, Tadeusz Robak, Robert Weinkove, Nikitin Ea, Evgueniy Hadjiev, John Pesko, David Gómez-Almaguer, Tamás Masszi
Publikováno v:
Leukemia & Lymphoma. 63:304-314
Venetoclax, a potent B-cell lymphoma-2 (BCL-2) inhibitor, has demonstrated clinical efficacy in chronic lymphocytic leukemia (CLL). VENICE II is an open-label, single-arm, phase 3b study (NCT02980731) evaluating the impact of venetoclax monotherapy (
Autor:
Abdullah A. Masud, Tara Cochrane, Stan Fort, Arnon P. Kater, Mary Ann Anderson, Tanya S. Rosenberg, Francesco Forconi, Simon Sharmokh, Matthew S. Davids, Brian Leber, Nikitin Ea, Fatih Demirkan, Yair Herishanu
e20011 Background: Neutropenia is a common hematologic Grade (Gr) 3+ adverse event (AE) recorded in patients with chronic lymphocytic leukemia (CLL) receiving venetoclax (VEN). In this analysis, we evaluated fixed duration VEN monotherapy given to pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6130314595e0140457401c1fb010aa43
https://avesis.deu.edu.tr/publication/details/bf381d5c-041f-40e2-bffd-8f05cc866edc/oai
https://avesis.deu.edu.tr/publication/details/bf381d5c-041f-40e2-bffd-8f05cc866edc/oai
Autor:
Tanya S. Rosenberg, Stan Fort, Simon Sharmokh, Mary Ann Anderson, Fatih Demirkan, Arnon P. Kater, Yair Herishanu, Nikitin Ea, Francesco Forconi, Tara Cochrane, Matthew S. Davids, Abdullah A. Masud, Brian Leber
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S220
Background Neutropenia is a common hematologic Grade (Gr) 3+ adverse event (AE) recorded in patients with chronic lymphocytic leukemia (CLL) receiving venetoclax (VEN). In this analysis, we evaluated fixed duration VEN monotherapy given to patients w
Autor:
Vikas Chandhoke, Ancha Baranova, Nikitin Ea, Elizabeth Nohelty, Aybike Birerdinc, Mikhail Skoblov, Ivan Panov, Ganiraju C. Manyam, Stephanie Coon, Andrey V. Marakhonov
Publikováno v:
Tumour Biology
Deletion of 13q14.3 and a candidate gene KCNRG (potassium channel regulating gene) is the most frequent chromosomal abnormality in B-cell chronic lymphocytic leukemia and is a common finding in multiple myeloma (MM). KCNRG protein may interfere with
Autor:
Anna Pestova, Rachel E. Ibbotson, Ancha Baranova, Francesco Gorreta, N. V. Makeeva, Stefan Einhorn, Marianne Hammarsund, Tariq Alsheddi, Martin Corcoran, Dmitry A. Shagin, Eugene R. Zabarovsky, T. V. Tyazhelova, Nikitin Ea, Andrey Ivanovich Vorobiev, Dmitry Ivanov, Kapanadze Bi, Mikhail Skoblov, N. K. Yankovsky, Karen Schlauch, Olle Sangfelt, Tatiana Borodina, Vikas Chandhoke, A. B. Poltaraus, Dan Grandér, Svetlana Nazarenko, David Oscier, Sergey Lukianov
Publikováno v:
Gene. 321:103-112
In the present study, we describe the human and mouse RFP2 gene structure, multiple RFP2 mRNA isoforms in the two species that have different 5' UTRs and a human-specific antisense transcript RFP2OS. Since the human RFP2 5' UTR is not conserved in mo
Autor:
T. V. Tyazhelova, Nikitin Ea, N. I. Kononenko, Dmitry Ivanov, Natalia Prevarskaya, Roman Skryma, Loic Lemonnier, N. K. Yankovsky, A. A. Pestova, Ancha Baranova, Yury Panchin
Publikováno v:
FEBS Letters. 539:156-160
We report the primary characterization of a new gene KCNRG mapped at chromosome band 13q14.3. This gene includes three exons and has two alternatively spliced isoforms that are expressed in normal tissues and in some tumor cell lines. Protein KCNRG h
Autor:
Poltaraus Ab, Yu Yu Lorie, Andrey Sudarikov, Ancha Baranova, Malakho Sg, B V Biderman, Nikitin Ea, M M Peklo, A.Y. Shevelev, B V Zingerman, Evgeny A. Moskalev, T N Vlasik, I A Vorob'ev, A I Vorobjev
Publikováno v:
Leukemialymphoma. 48(5)
Mutational status of immunoglobulin variable region genes (VH-genes) is known as the strongest predictor of long term prognosis in B-CLL. However, applications in the routine clinical practice are time consuming, and therefore some other predictions
Autor:
Emanuele Zucca, Sergio Cogliatti, Davide Rossi, Stephan Stilgenbauer, David Oscier, Jonathan C. Strefford, Timothy C. Greiner, Francoise Berger, Kostas Stamatopoulos, Valter Gattei, András Matolcsy, Luca Arcaini, Hana Votavova, Richard Rosenquist, Gianluca Gaidano, Andrea Rinaldi, Giorgio Inghirami, Theodora Papadaki, Paola Mv Rancoita, Francesco Forconi, Steven H. Swerdlow, Francesco Bertoni, Laura Pasqualucci, Fiona Murray, Ekaterina Chigrinova, Ken H. Young, Miguel A. Piris, Dominic V. Spagnolo, Marco Lucioni, Alberto Zamò, Nikitin Ea, Ivo Kwee, Wing C. Chan, Roberto Marasca, Marco Ladetto
Publikováno v:
Blood. 118:263-263
Abstract 263 RS represents the development of a diffuse large B-cell lymphoma (DLBCL) in the context of chronic lymphocytic leukemia (CLL). The pathogenesis of RS is still largely unknown. Analysis of RS has been often focused on the study of lesions
Autor:
Aybike Birerdinc, Ancha Baranova, Nikitin Ea, Khomenkov, Chandhoke, Andrey V. Marakhonov, B V Biderman, Sandra Page, Andrey Sudarikov, Elizabeth Nohelty, Mikhail Skoblov
Publikováno v:
Drug News & Perspectives. 23:625
Chronic lymphocytic leukemia (CLL) represents 22-30% of all leukemia cases, thus being the most commonly diagnosed form of adult leukemia in the Western world. On a cellular level, the disease progresses due to the prolonged survival of B-cell CLL ce
Publikováno v:
Blood. 114:4406-4406
Abstract 4406 We have found only one study aimed to find prognostic significance of abdominal lymph nodes in CLL (E. Montserrat et al, 2007). It was shown that Rai O CLL patients with enlarged abdominal lymph nodes had inferior survival. It merely me